This federal contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $7,154.84, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 14, 2024. The contract is a delivery order with a firm fixed price, and the ultimate completion date is set for November 15, 2024. This contract is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/13/25, 9:19 AM